METTL1 and nasopharyngeal carcinoma: For instance, METTL1/WDR4 promotes NPC growth and metastasis by upregulating the WNT/β-catenin signaling pathway and promoting epithelial-mesenchymal transition (EMT) and chemoresistance to cisplatin and docetaxel [20].